Delivery Order SPE2DB24D3013-SPE2DB25FFQPG
- Not listed
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,157.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 9, 2025, valued at $1,227.09 for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packages of 30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 10, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $7,988.25. This is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet units in a quantity of 30, with a ceiling value of $1,386.82. The order represents a competitively awarded, non-set-aside delivery order under a firm fixed price arrangement, with an ultimate completion date of August 25, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.48 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) with a ceiling value of $1,393.00. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,314.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count packages). The contract, executed on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQPGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,209.99 on September 15, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet unit dose packages (30 count). The contract is non-competitive and utilizes firm fixed pricing, with an ultimate completion date of September 16, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company maintains an extensive portfolio of competitively awarded delivery orders with the Defense Logistics Agency, supplying a wide range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. This particular order for the hypertension medication Telmisartan-HCTZ supports the company's role in fulfilling medical supply needs for military and veteran healthcare systems through the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/15/25 |